Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhancing Explainable AI Stability with Realistic Synthetic Data for Cardiovascular Risk Prediction.

Studies in health technology and informatics·2026

Same author

Knowledge graph embedding and alignment of incomplete electronic health records for critical care applications.

Journal of biomedical semantics·2026

Same author

Rule-augmented constraint learning for semantic error detection in MIMIC-III knowledge graph.

International journal of medical informatics·2026

Same author

CMEO: a metadata-centric ontology for clinical studies exploration and harmonization assessment.

BMC medical informatics and decision making·2025

Same author

Privacy preservation in blockchain-based healthcare data sharing: A systematic review.

Peer-to-peer networking and applications·2025

Same author

Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine.

Nature reviews. Clinical oncology·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Towards pharmacogenomics knowledge discovery with the semantic web.

Michel Dumontier¹, Natalia Villanueva-Rosales

¹Department of Biology, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada K1S 5B6. michel_dumontier@carleton.ca

Briefings in Bioinformatics

|February 26, 2009

Summary

Pharmacogenomics uses genetic variation to predict drug responses for better healthcare. Semantic web technologies enhance pharmacogenomics knowledge discovery and personalized medicine through automated reasoning.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Related Experiment Videos

Last Updated: Jun 25, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

Pharmacogenomics
Bioinformatics
Computational Biology

Background:

Pharmacogenomics links genetic variation to drug response, crucial for personalized medicine.
Existing XML methods facilitate pharmacogenomics data sharing but lack semantic understanding.
Semantic web technologies offer advanced opportunities for pharmacogenomics knowledge discovery.

Purpose of the Study:

To explore the application of semantic web technologies in pharmacogenomics.
To demonstrate enhanced knowledge discovery and question answering in personalized medicine.
To leverage machine-understandable semantics for pharmacogenomic data.

Main Methods:

Utilizing semantic web technologies and ontologies for knowledge representation.
Implementing automated reasoning over expressive ontologies.
Developing intuitive knowledge capture mechanisms for pharmacogenomics.
Applying these methods within a personalized medicine project framework.

Main Results:

Demonstrated enhanced pharmacogenomics knowledge discovery through machine-understandable semantics.
Enabled sophisticated question answering regarding therapeutic, pharmacological, and genetic aspects.
Facilitated personalized medicine by improving knowledge accessibility and utilization.

Conclusions:

Semantic web technologies significantly advance pharmacogenomics knowledge discovery.
Automated reasoning over ontologies is key to unlocking the potential of pharmacogenomics.
This approach supports the development of more effective personalized medicine strategies.